SCHEMBL20565753

SCHEMBL20565753

O=P(c1ccccc1)(c1ccccc1)c1cccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.42
KMO O15229 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
GP6 Q9HCN6 1/20 0.41
MEN1 O00255 3/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 3/20 0.40
KMT2A Q03164 3/20 0.40
GRM5 P41594 1/20 0.39
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
GLA P06280 1/20 0.38
ADORA1 P30542 3/20 0.37
ADORA2A P29274 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
POLB P06746 1/20 0.37
ADORA2B P29275 1/20 0.37
PTPN1 P18031 1/20 0.37
PTPN5 P54829 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30141901 1.00 HDAC8 (0.42) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL30686683 1.00 HDAC8 (0.42) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL29546850 0.95 HDAC8 (0.42) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL17659989 0.95 HDAC8 (0.42) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL22639221 0.93 MEN1 (0.43) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL21122454 0.93 MEN1 (0.43) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL22639274 0.93 MEN1 (0.43) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL22639275 0.93 MEN1 (0.43) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL22639356 0.93 MEN1 (0.43) HDAC8KMOL3MBTL1GP6MEN1
SCHEMBL21122648 0.93 MEN1 (0.43) HDAC8KMOL3MBTL1GP6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed
EP-3407401-A1 ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER AND A DEVICE Novaled GmbH (DE) 2018-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 HDAC8 4517/4885KMO 1436/4885L3MBTL1 812/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 HDAC8 4517/4885KMO 1436/4885L3MBTL1 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.